VolitionRx shareholders approve share issuance to Lind Global and reverse stock split authorization

VOLITIONRX LTD

Proposal 1 (issuance >20% to Lind Global): 44.15M for, 14.10M against, 1.11M abstain, 21.15M broker non-votes approved.
Proposal 2 (reverse split authorization): 62.84M for, 16.45M against, 1.22M abstain; board may choose ratio 1:5 to 1:20.
Record date Feb 9, 2026: 135.57M shares outstanding; 80.51M shares present at special meeting on March 31, 2026.
No other matters were presented for stockholder action at the special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.